Evoq Remedies Limited (BOM:543500)
India · Delayed Price · Currency is INR 1.750
-0.020 (-1.13%)
At close: Aug 4, 2026
Evoq Remedies Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 44 | 57 | 64 | 118 | 177 | 307 | |
Market Cap Growth | -51.39% | -10.16% | -45.94% | -33.26% | -42.52% | - |
Enterprise Value | 44 | 54 | 89 | 130 | 282 | 345 |
Last Close Price | 1.75 | 2.30 | 2.56 | 8.67 | 12.99 | 22.60 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | 72.27 | 26.06 | 10.91 | 28.17 |
PS Ratio | 0.16 | 0.21 | 0.45 | 1.87 | 0.67 | 1.83 |
PB Ratio | 0.10 | 0.13 | 0.14 | 0.47 | 0.71 | 1.33 |
P/TBV Ratio | 0.10 | 0.13 | 0.14 | 0.47 | 0.71 | 1.33 |
P/FCF Ratio | - | - | - | 2.22 | - | - |
P/OCF Ratio | - | - | - | 2.22 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.17 | 0.20 | 0.63 | 2.06 | 1.07 | 2.06 |
EV/EBITDA Ratio | - | - | 50.33 | 21.03 | 12.33 | - |
EV/EBIT Ratio | - | - | 69.52 | 21.28 | 12.35 | 23.57 |
EV/FCF Ratio | - | - | - | 2.45 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.00 | 0.00 | - | 0.17 | 0.39 | 0.35 |
Debt / EBITDA Ratio | - | - | - | 6.85 | 4.18 | - |
Debt / FCF Ratio | - | - | - | 0.80 | - | - |
Net Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.16 | 0.38 | 0.22 |
Net Debt / EBITDA Ratio | -0.34 | -0.34 | -1.21 | 6.65 | 4.12 | - |
Net Debt / FCF Ratio | -0.24 | -0.24 | 0.01 | 0.78 | -2.16 | -0.18 |
Asset Turnover | 0.53 | 0.53 | 0.33 | 0.18 | 0.77 | 0.81 |
Inventory Turnover | 13.10 | 13.10 | 4.90 | 0.61 | 13.73 | 29.53 |
Quick Ratio | 0.51 | 0.51 | 1.61 | 0.16 | 1.72 | 2.80 |
Current Ratio | 6.77 | 6.77 | 9.10 | 3.17 | 3.45 | 3.28 |
Return on Equity (ROE) | -0.54% | -0.54% | 0.25% | 1.81% | 6.75% | 9.13% |
Return on Assets (ROA) | -0.31% | -0.31% | 0.18% | 1.06% | 4.19% | 4.42% |
Return on Invested Capital (ROIC) | -0.57% | -0.57% | 0.24% | 1.42% | 5.19% | 7.56% |
Return on Capital Employed (ROCE) | -0.60% | -0.60% | 0.30% | 2.40% | 9.20% | 6.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -5.51% | -4.19% | 1.38% | 3.84% | 9.17% | 3.55% |
FCF Yield | -6.47% | -4.92% | -233.45% | 45.02% | -24.67% | -89.92% |
Buyback Yield / Dilution | 3.65% | 3.65% | -83.09% | - | -35.84% | -900.56% |